Results for tag: "Benralizumab"

Benralizumab is a monoclonal antibody used to treat severe asthma. It is a type of biologic drug, which works by targeting and blocking a specific protein in the body that is involved in the inflammation process. Benralizumab is administered as an intravenous infusion and is used in combination with other asthma medications. It is approved for use in adults and adolescents aged 12 years and older. Benralizumab is used to treat severe asthma that is not adequately controlled with inhaled corticosteroids and long-acting beta-agonists. It is also used to reduce the frequency of exacerbations in patients with severe asthma. Benralizumab is a relatively new drug and is still being studied to determine its long-term safety and efficacy. In the Benralizumab market, some of the major players include AstraZeneca, GlaxoSmithKline, Sanofi, and Teva Pharmaceuticals. Other companies involved in the market include Boehringer Ingelheim, Merck, and Novartis. Show Less Read more